Medico Intercontinental Limited (BOM:539938)
India
· Delayed Price · Currency is INR 33.04
+0.69 (2.13%)
At close: Mar 10, 2026
Medico Intercontinental Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 834.55 | 960.15 | 713.55 | 762.26 | 742.6 | 697.41 | Upgrade
|
| Other Revenue | 11.13 | 2.61 | 1.52 | 2.96 | 1.2 | 0.29 | Upgrade
|
| Revenue | 845.68 | 962.76 | 715.07 | 765.22 | 743.8 | 697.7 | Upgrade
|
| Revenue Growth (YoY) | -6.55% | 34.64% | -6.55% | 2.88% | 6.61% | -14.93% | Upgrade
|
| Cost of Revenue | 641.81 | 746.15 | 548.77 | 623.13 | 608.51 | 576.26 | Upgrade
|
| Gross Profit | 203.88 | 216.61 | 166.3 | 142.09 | 135.29 | 121.43 | Upgrade
|
| Selling, General & Admin | 96.86 | 64.47 | 64.21 | 43.67 | 44.47 | 39.02 | Upgrade
|
| Other Operating Expenses | 59.49 | 64.37 | 39.91 | 40.69 | 37.51 | 32.81 | Upgrade
|
| Operating Expenses | 199.31 | 136.9 | 106.97 | 86.37 | 83.99 | 73.16 | Upgrade
|
| Operating Income | 4.56 | 79.71 | 59.34 | 55.72 | 51.3 | 48.28 | Upgrade
|
| Interest Expense | -65.86 | -9.67 | -4.8 | -6.11 | -8.65 | -12.67 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.28 | -0.28 | -0.13 | -0.08 | -0.09 | -0.12 | Upgrade
|
| EBT Excluding Unusual Items | -61.47 | 69.75 | 54.41 | 49.53 | 42.56 | 35.48 | Upgrade
|
| Impairment of Goodwill | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 | -0.05 | Upgrade
|
| Pretax Income | -61.49 | 69.73 | 54.39 | 49.5 | 42.53 | 35.43 | Upgrade
|
| Income Tax Expense | 13.31 | 19.16 | 14.91 | 13.42 | 11.53 | 9.67 | Upgrade
|
| Net Income | -13.8 | 50.57 | 39.47 | 36.08 | 31 | 25.76 | Upgrade
|
| Net Income to Common | -13.8 | 50.57 | 39.47 | 36.08 | 31 | 25.76 | Upgrade
|
| Net Income Growth | - | 28.13% | 9.39% | 16.41% | 20.32% | 9.31% | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 6 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 6 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | -0.03% | - | 55.51% | 97.92% | - | - | Upgrade
|
| EPS (Basic) | -1.38 | 5.06 | 3.95 | 5.61 | 9.54 | 7.93 | Upgrade
|
| EPS (Diluted) | -1.38 | 5.06 | 3.95 | 5.61 | 9.54 | 7.93 | Upgrade
|
| EPS Growth | - | 28.13% | -29.66% | -41.19% | 20.32% | 9.31% | Upgrade
|
| Free Cash Flow | - | -91.14 | 43.42 | -105.25 | 36.38 | 56.09 | Upgrade
|
| Free Cash Flow Per Share | - | -9.11 | 4.34 | -16.37 | 11.20 | 17.27 | Upgrade
|
| Dividend Per Share | - | - | - | 0.100 | - | - | Upgrade
|
| Gross Margin | 24.11% | 22.50% | 23.26% | 18.57% | 18.19% | 17.41% | Upgrade
|
| Operating Margin | 0.54% | 8.28% | 8.30% | 7.28% | 6.90% | 6.92% | Upgrade
|
| Profit Margin | -1.63% | 5.25% | 5.52% | 4.71% | 4.17% | 3.69% | Upgrade
|
| Free Cash Flow Margin | - | -9.47% | 6.07% | -13.75% | 4.89% | 8.04% | Upgrade
|
| EBITDA | 16.55 | 87.78 | 62.18 | 57.72 | 53.32 | 49.61 | Upgrade
|
| EBITDA Margin | 1.96% | 9.12% | 8.70% | 7.54% | 7.17% | 7.11% | Upgrade
|
| D&A For EBITDA | 11.98 | 8.07 | 2.85 | 2.01 | 2.02 | 1.33 | Upgrade
|
| EBIT | 4.56 | 79.71 | 59.34 | 55.72 | 51.3 | 48.28 | Upgrade
|
| EBIT Margin | 0.54% | 8.28% | 8.30% | 7.28% | 6.90% | 6.92% | Upgrade
|
| Effective Tax Rate | - | 27.48% | 27.42% | 27.11% | 27.11% | 27.29% | Upgrade
|
| Revenue as Reported | 846.63 | 963.71 | 717.57 | 767.38 | 745.66 | 699.19 | Upgrade
|
| Advertising Expenses | - | 12.94 | 21.33 | 7.7 | 17.74 | 13.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.